- Home
- OVBC vs MCRB Comparison
OVBC vs MCRB Comparison
Compare OVBC & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVBC
- MCRB
- Stock Information
- Founded
- OVBC 1872
- MCRB 2010
- Country
- OVBC United States
- MCRB United States
- Employees
- OVBC N/A
- MCRB N/A
- Industry
- OVBC Major Banks
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- OVBC Finance
- MCRB Health Care
- Exchange
- OVBC Nasdaq
- MCRB Nasdaq
- Market Cap
- OVBC 163.6M
- MCRB 165.3M
- IPO Year
- OVBC N/A
- MCRB 2015
- Fundamental
- Price
- OVBC $38.90
- MCRB $18.03
- Analyst Decision
- OVBC
- MCRB Hold
- Analyst Count
- OVBC 0
- MCRB 4
- Target Price
- OVBC N/A
- MCRB $73.67
- AVG Volume (30 Days)
- OVBC 10.1K
- MCRB 245.0K
- Earning Date
- OVBC 10-27-2025
- MCRB 11-12-2025
- Dividend Yield
- OVBC 2.47%
- MCRB N/A
- EPS Growth
- OVBC 24.74
- MCRB N/A
- EPS
- OVBC 2.94
- MCRB 10.22
- Revenue
- OVBC $63,493,000.00
- MCRB N/A
- Revenue This Year
- OVBC N/A
- MCRB N/A
- Revenue Next Year
- OVBC N/A
- MCRB N/A
- P/E Ratio
- OVBC $12.66
- MCRB $1.76
- Revenue Growth
- OVBC 13.62
- MCRB N/A
- 52 Week Low
- OVBC $21.86
- MCRB $6.53
- 52 Week High
- OVBC $40.99
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- OVBC 75.35
- MCRB 52.55
- Support Level
- OVBC $36.75
- MCRB $14.22
- Resistance Level
- OVBC $37.33
- MCRB $24.67
- Average True Range (ATR)
- OVBC 1.00
- MCRB 2.08
- MACD
- OVBC 0.08
- MCRB -0.38
- Stochastic Oscillator
- OVBC 100.00
- MCRB 36.48
About OVBC Ohio Valley Banc Corp.
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.